Skip to main content
Premium Trial:

Request an Annual Quote

Stanley Lapidus, Noubar Afeyan, Stephen Lombardi

Helicos shuffled some executives last week, with company co-founder and CEO Stanley Lapidus taking on the job of chairman from Noubar Afeyan and Stephen Lombardi moving up to the role of president while retaining his job as COO. Afeyan was named lead independent director on the company’s board.
 
Lombardi was previously COO and vice president of Helicos. Prior to joining the company, he was a senior VP at Affymetrix and before that he spent 16 years at Applied Biosystems as an executive in the company’s DNA sequencing and genetic analysis business.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more